SEC ownership of OptimizeRx Corp

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001448431.

Comparable stake leader

Whetstone Capital Advisors, LLC

Disclosed value leader

Whetstone Capital Advisors, LLC

Comparable rows

4/50

Latest evidence

01 Oct 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
4 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Whetstone Capital Advisors, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
01 Oct 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001448431
Issuer location
Waltham, MA

Ownership snapshot

Top shareholders of OptimizeRx Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Whetstone Capital Advisor...
Disclosed value leader
Whetstone Capital Advisor...
Comparable rows
4/50
Latest evidence
01 Oct 2026
13D/G 13F 3/4/5 Lead comparable stake: 8.2% 46 rows are not safely comparable across share classes. 13D/G row: Whetstone Capital Advisors, LLC Showing 1-8 of 50 holder rows.

Quick read

Whetstone Capital Advisors, LLC leads the comparable SEC ownership view at 8.2%.

4 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Whetstone Capital Advisors, LLC's linked filing trail.
Comparable ownership Top 4
Whetstone Capital Advisors, LLC 8.2%
ROYCE & ASSOCIATES LP 7%
KENNEDY CAPITAL MANAGEMENT LLC 6.7%
BlackRock, Inc. 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Whetstone Capital Advisors, LLC
13D/G 13F
Company
8.2%
Reported 13D/G · 18 Apr 2025
$13,061,904
1,508,303 shares
$0 18 Apr 2025
ROYCE & ASSOCIATES LP
13D/G 13F
Company
7%
Reported 13D/G · 30 Sep 2026
$10,980,594
1,315,057 shares
+$1,884,230 30 Sep 2026
KENNEDY CAPITAL MANAGEMENT LLC
13D/G 13F
Company
6.7%
Reported 13D/G · 07 Jul 2026
$7,143,702
1,248,899 shares
$0 07 Jul 2026
BlackRock, Inc.
13F 13D/G
Company
1.8%
Reported 13D/G · 30 Jun 2026
$2,547,585
445,382 shares
— 30 Jun 2026
Miriam J. Paramore
3/4/5
PRESIDENT AND CSO
—
mixed-class rows
$5,568,610
236,416 shares
mixed-class rows
— 02 Dec 2021
William J. Febbo
3/4/5
CEO, Director
—
mixed-class rows
$4,608,010
658,642 shares
mixed-class rows
— 14 Feb 2025
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$4,001,735
699,604 shares
— 30 Jun 2026
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
13F
—
denominator unverified
$3,625,576
633,842 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 11 Nov 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to OptimizeRx Corp. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
Miriam J. Paramore
Net 12M change
$0
Latest report
01 Oct 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Miriam J. Paramore President And Cso $5,568,610 Mixed 02 Dec 2021
William J. Febbo CEO, Director $4,608,010 Mixed 14 Feb 2025
Douglas P. Baker Chief Financial Officer $2,763,393 Mixed 05 Oct 2021
James Paul Lang Director $2,724,496 Mixed 09 Jun 2026
Stephen L. Silvestro Chief Executive Officer $1,049,911 Mixed 21 Aug 2026
Doug Besch Chief Product & Tech Officer $894,030 Mixed 23 Dec 2025
Gus D. Halas Director $865,908 Mixed 05 Jun 2024
Edward Stelmakh Chief Finance & Strat Officer $808,716 Mixed 21 Aug 2026
Ellen O'Connor Vos Director $672,958 Mixed 09 Jun 2026
Gregory D. Wasson Director $575,876 Mixed 09 Jun 2026
Andrew J. D'Silva Chief Business Officer $567,687 Mixed 01 Oct 2026
Marion K. Odence-Ford Chief Legal & Admin Officer $517,128 Mixed 21 Aug 2026
Patrick D. Spangler Director $494,436 Mixed 09 Jun 2026
Theresa Greco Chief Commercial Officer $446,351 Mixed 15 May 2026
Cathy Klema Director $352,540 Mixed 09 Jun 2026
Mariyamma Varghese Presti Director $190,397 Mixed 09 Jun 2026
Brendan W. Merrell Chief Operating Officer $144,069 Mixed 21 Aug 2026
Brian Clark McCarthy Chief Revenue Officer $102,003 Mixed 02 Aug 2024
Todd Inman Chief Technology Officer $30,548 Mixed 01 Mar 2023

Recent insider transactions for OptimizeRx Corp

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Andrew J. D'Silva OPRX Common Stock Tax liability -0.42% -414 99,246 01 Oct 2026 Direct
Andrew J. D'Silva OPRX Common Stock Tax liability -1.42% -1,432 99,660 01 Sep 2026 Direct
Brendan W. Merrell OPRX Common Stock Tax liability -3.89% -1,020 25,187 21 Aug 2026 Direct
Stephen L. Silvestro OPRX Common Stock Tax liability -0.94% -1,737 183,551 21 Aug 2026 Direct
Marion K. Odence-Ford OPRX Common Stock Tax liability -1.66% -1,529 90,407 21 Aug 2026 Direct
Andrew J. D'Silva OPRX Common Stock Tax liability -2.78% -1,243 43,492 21 Aug 2026 Direct
Edward Stelmakh OPRX Common Stock Tax liability -1.12% -1,381 121,791 21 Aug 2026 Direct
Stephen L. Silvestro OPRX Common Stock Award 43.2% 79,200 262,751 20 Aug 2026 Direct
Andrew J. D'Silva OPRX Common Stock Award 132.4% 57,600 101,092 20 Aug 2026 Direct
Brendan W. Merrell OPRX Common Stock Award 228.7% 57,600 82,787 20 Aug 2026 Direct
Marion K. Odence-Ford OPRX Common Stock Award 63.7% 57,600 148,007 20 Aug 2026 Direct
Cathy Klema OPRX Common Stock Award 159.6% 34,517 56,137 09 Jun 2026 Direct
James Paul Lang OPRX Common Stock Award 8.64% 34,517 433,837 09 Jun 2026 Direct
Mariyamma Varghese Presti OPRX Common Stock Award 132.1% 17,258 30,318 09 Jun 2026 Direct
Patrick D. Spangler OPRX Common Stock Award 78.1% 34,517 78,732 09 Jun 2026 Direct
Vos Ellen O'Connor OPRX Common Stock Award 47.5% 34,517 107,159 09 Jun 2026 Direct
Gregory D. Wasson OPRX Common Stock Award 60.4% 34,517 91,700 09 Jun 2026 Direct
Theresa Greco OPRX Common Stock Tax liability -2.46% -1,793 71,075 15 May 2026 Direct
Stephen L. Silvestro OPRX Common Stock Tax liability -2.74% -5,219 185,288 15 May 2026 Direct
Mariyamma Varghese Presti OPRX Common Stock Award 13,060 13,060 01 May 2026 Direct
Marion K. Odence-Ford OPRX Common Stock Tax liability -1.49% -1,386 91,936 11 Feb 2026 Direct
Marion K. Odence-Ford OPRX Common Stock Options Exercise 4.48% 4,000 93,322 11 Feb 2026 Direct
Marion K. Odence-Ford OPRX Restricted Stock Units Options Exercise -100% -4,000 0 11 Feb 2026 Direct
Stephen L. Silvestro OPRX Common Stock Tax liability -1.73% -3,361 190,507 23 Dec 2025 Direct
Theresa Greco OPRX Common Stock Tax liability -1.91% -1,420 72,868 23 Dec 2025 Direct
Marion K. Odence-Ford OPRX Common Stock Tax liability -4.34% -4,051 89,322 23 Dec 2025 Direct
Doug Besch OPRX Common Stock Tax liability -5.75% -4,079 66,876 23 Dec 2025 Direct
Edward Stelmakh OPRX Common Stock Tax liability -2.88% -3,658 123,172 23 Dec 2025 Direct
Edward Stelmakh OPRX Common Stock Tax liability -1.08% -1,388 126,830 19 Dec 2025 Direct
Edward Stelmakh OPRX Common Stock Options Exercise 4.26% 5,237 128,218 19 Dec 2025 Direct
Edward Stelmakh OPRX Restricted Stock Units Options Exercise -50% -5,237 5,237 19 Dec 2025 Direct
Stephen L. Silvestro OPRX Common Stock Tax liability -0.82% -1,594 193,868 19 Dec 2025 Direct
Stephen L. Silvestro OPRX Common Stock Options Exercise 3.47% 6,546 195,462 19 Dec 2025 Direct
Stephen L. Silvestro OPRX Restricted Stock Units Options Exercise -50% -6,546 6,547 19 Dec 2025 Direct
Marion K. Odence-Ford OPRX Common Stock Tax liability -1.22% -1,153 93,373 19 Dec 2025 Direct
Marion K. Odence-Ford OPRX Common Stock Options Exercise 4.34% 3,928 94,526 19 Dec 2025 Direct
Marion K. Odence-Ford OPRX Restricted Stock Units Options Exercise -50% -3,928 3,928 19 Dec 2025 Direct
Brendan W. Merrell OPRX Common Stock Tax liability -1.09% -289 26,207 19 Dec 2025 Direct
Andrew J. D'Silva OPRX Common Stock Tax liability -1.55% -703 44,735 19 Dec 2025 Direct
Doug Besch OPRX Common Stock Tax liability -0.81% -581 70,955 19 Dec 2025 Direct
Doug Besch OPRX Common Stock Options Exercise 2.82% 1,964 71,536 19 Dec 2025 Direct
Doug Besch OPRX Restricted Stock Units Options Exercise -50% -1,964 1,964 19 Dec 2025 Direct
Brendan W. Merrell OPRX Common Stock Tax liability -2.62% -712 26,496 11 Dec 2025 Direct
Andrew J. D'Silva OPRX Common Stock Tax liability -1.87% -868 45,438 11 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .